Search Results - "Paul, Mariel C."
-
1
A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer
Published in Nature medicine (01-11-2014)“…The next generation of genetically engineered mouse models of pancreatic cancer involving a new inducible dual-recombinase system that combines Flp- FRT and…”
Get full text
Journal Article -
2
EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer
Published in Molecular cancer therapeutics (01-04-2019)“…The EPHA2 tyrosine kinase receptor is implicated in tumor progression and targeted therapies resistance. We evaluated EPHA2 as a potential resistance marker to…”
Get full text
Journal Article -
3
E-Cadherin Regulates Metastasis of Pancreatic Cancer In Vivo and Is Suppressed by a SNAIL/HDAC1/HDAC2 Repressor Complex
Published in Gastroenterology (New York, N.Y. 1943) (01-07-2009)“…Background & Aims Early metastasis is a hallmark of pancreatic ductal adenocarcinoma and responsible for >90% of pancreatic cancer death. Because little is…”
Get full text
Journal Article -
4
Non-canonical functions of SNAIL drive context-specific cancer progression
Published in Nature communications (07-03-2023)“…SNAIL is a key transcriptional regulator in embryonic development and cancer. Its effects in physiology and disease are believed to be linked to its role as a…”
Get full text
Journal Article -
5
EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients
Published in Gastroenterology (New York, N.Y. 1943) (01-07-2017)“…Background & Aims Inhibitors of the epidermal growth factor receptor (EGFR) are the first-line therapy for patients with metastatic colorectal tumors without…”
Get full text
Journal Article -
6
MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib
Published in Nucleic acids research (15-09-2014)“…The c-MYC (MYC afterward) oncogene is well known for driving numerous oncogenic programs. However, MYC can also induce apoptosis and this function of MYC…”
Get full text
Journal Article -
7
Efemp1 and p27(Kip1) modulate responsiveness of pancreatic cancer cells towards a dual PI3K/mTOR inhibitor in preclinical models
Published in Oncotarget (01-02-2013)“…Pancreatic ductal adenocarcinoma (PDAC) remains a dismal disease with a poor prognosis and targeted therapies have failed in the clinic so far. Several…”
Get full text
Journal Article -
8
Generation of an 870 kb deletion encompassing the Skt/Etl4 locus by combination of inter- and intra-chromosomal recombination
Published in BMC genetics (18-12-2015)“…Etl4(lacZ) (Enhancer trap locus 4) and Skt(Gt) (Sickle tail) are lacZ reporter gene integrations into the same locus on mouse chromosome 2 targeting a gene…”
Get full text
Journal Article -
9
Efemp1 and p27Kip1 modulate responsiveness of pancreatic cancer cells towards a dual PI3K/mTOR inhibitor in preclinical models
Published in Oncotarget (28-02-2013)“…Pancreatic ductal adenocarcinoma (PDAC) remains a dismal disease with a poor prognosis and targeted therapies have failed in the clinic so far. Several…”
Get full text
Journal Article